Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bionano Genomics

3.75
+0.07001.90%
Post-market: 3.750.00000.00%19:51 EDT
Volume:49.87K
Turnover:186.60K
Market Cap:12.62M
PE:-0.04
High:3.78
Open:3.75
Low:3.70
Close:3.68
Loading ...

Stock Track | Bionano Genomics Plunges 8% in Pre-market Following Mixed 2024 Results and Analyst Caution

Stock Track
·
03 Apr

Stock Track | Bionano Genomics Plunges 8% After-Hours on Mixed 2024 Results and Maintained Hold Rating

Stock Track
·
03 Apr

Bionano Genomics Is Maintained at Sector Perform by Scotiabank

Dow Jones
·
03 Apr

Stock Track | Bionano Genomics Soars 5% as Scotiabank Quadruples Price Target, Revenue Beats Expectations

Stock Track
·
02 Apr

Scotiabank Sticks to Its Hold Rating for BioNano Genomics (BNGO)

TIPRANKS
·
02 Apr

Bionano Genomics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
02 Apr

U.S. RESEARCH ROUNDUP- Beacon Roofing Supply, Carvana, Reinsurance Group of America

Reuters
·
02 Apr

Stock Track | Bionano Genomics (BNGO) Soars 8.24% Following Positive Q4 2024 Earnings Report

Stock Track
·
01 Apr

Bionano Genomics Inc (BNGO) Q4 2024 Earnings Call Highlights: Strategic Cost Reductions and ...

GuruFocus.com
·
01 Apr

Bionano Genomics Q4 2024 Earnings Call Summary and Q&A Highlights: Strategic Focus on Routine Users and Optical Genome Mapping

Earnings Call
·
01 Apr

Bionano Genomics (BNGO) Q4 2024 Earnings Call Transcript

Motley Fool Transcribing
·
01 Apr

Bionano Genomics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
01 Apr

Stock Track | Bionano Genomics Soars 7.53% After-Hours on Strong Q4 Results and Positive 2025 Outlook

Stock Track
·
01 Apr

Bionano Genomics Inc - Expects FY 2025 Revenue Between $29 Million and $32 Million

THOMSON REUTERS
·
01 Apr

Bionano Genomics Outlook Q1 Revenue $6.2 Mln to $6.3 Mln

THOMSON REUTERS
·
01 Apr

Press Release: Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025

Dow Jones
·
01 Apr

Bionano Genomics Inc expected to post a loss of $6.00 a share - Earnings Preview

Reuters
·
29 Mar

Stock Track | Bionano Genomics Soars 5.23% Pre-Market on Breakthrough Neural Tube Defects Study Using OGM Technology

Stock Track
·
24 Mar

Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect

GlobeNewswire
·
24 Mar

Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting

GlobeNewswire
·
18 Mar